The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and β-cell function

British Journal of Nutrition

Volumn 114, Issue 2, 2015, Pages 161-168

  Thibault, Véronique ^a   Morisset, Anne Sophie ^a   Brown, Christine ^b   Carpentier, André C ^b,c   Baillargeon, Jean Patrice ^b,c   Langlois, Marie France ^b,c   Gagnon, Claudia ^a,d,e  

^a Université Laval   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e Institute of Nutraceuticals and Functional Foods   (Canada)

Author keywords

Insulin secretion; Insulin sensitivity; Vitamin D; Weight loss; Cell function

Indexed keywords

25 HYDROXYVITAMIN D; INSULIN; 25-HYDROXYVITAMIN D; C PEPTIDE; VITAMIN D;

ADULT; ARTICLE; BODY MASS; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; MALE; OBESITY; PANCREAS ISLET CELL FUNCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); VITAMIN BLOOD LEVEL; WEIGHT REDUCTION; AGED; ANALOGS AND DERIVATIVES; BLOOD; BODY COMPOSITION; DIET SUPPLEMENTATION; INSULIN RESISTANCE; LIFESTYLE; METABOLISM; MIDDLE AGED; PANCREAS ISLET BETA CELL; PHYSIOLOGY; PROSPECTIVE STUDY; SECRETION (PROCESS); STATISTICAL MODEL;

AGED; BODY COMPOSITION; BODY MASS INDEX; C-PEPTIDE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIFE STYLE; LINEAR MODELS; MALE; MIDDLE AGED; PREDIABETIC STATE; PROSPECTIVE STUDIES; VITAMIN D; WEIGHT LOSS;

EID: 84938555984     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515001610     Document Type: Article

References (30)

1. Wortsman J, Matsuoka LY, Chen TC, et al. (2000). Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690-693
2. Shakur YA, Tarasuk V, Corey P, et al. (2012). A comparison of micronutrient inadequacy and risk of high micronutrient intakes among vitamin and mineral supplement users and nonusers in Canada. J Nutr 142, 534-540
3. National Task Force on the Prevention and Treatment of Obesity. (2000). Overweight, obesity, and health risk. Arch Intern Med 160, 898-904
4. Song Y, Wang L, Pittas AG, et al. (2013). Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36, 1422-1428
5. Knowler WC, Barrett-Connor E, Fowler SE, et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393-403
6. Tuomilehto J, Lindstrom J, Eriksson JG, et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344, 1343-1350
7. Mason C, Xiao L, Imayama I, et al. (2011). Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr 94, 95-103
8. Rock CL, Emond JA, Flatt SW, et al. (2012). Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity 20, 2296-2301
9. Kitabchi AE, Temprosa M, Knowler WC, et al. (2005). Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 54, 2404-2414
10. Mitri J, Dawson-Hughes B, Hu FB, et al. (2011). Effects of vitamin D and calcium supplementation on pancreatic b cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94, 486-494
11. von Hurst PR, Stonehouse W, & Coad J. (2010). Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient -a randomised, placebo-controlled trial. Br J Nutr 103, 549-555
12. Tzotzas T, Papadopoulou FG, Tziomalos K, et al. (2010). Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 95, 4251-4257
13. Gagnon C, Brown C, Couture C, et al. (2011). A cost-effective moderate-intensity interdisciplinary weight-management programme for individuals with prediabetes. Diabetes Metab 37, 410-418
14. Beriault K, Carpentier AC, Gagnon C, et al. (2009). Reproducibility of the 6-minute walk test in obese adults. Int J Sports Med 30, 725-727
15. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. (2002). ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166, 111-117
16. Reinehr T, De Sousa G, Alexy U, et al. (2007). Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 157, 225-232
17. Festa A, D'Agostino R Jr, Williams K, et al. (2001). The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25, 1407-1415
18. Hu FB, Meigs JB, Li TY, et al. (2004). Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53, 693-700
19. Ho TP, Zhao X, Courville AB, et al. (2015). Effects of a 12-month moderate weight loss intervention on insulin sensitivity and inflammation status in nondiabetic overweight and obese subjects. Horm Metab Res 47, 289-296
20. Shoelson SE, Lee J, & Goldfine AB. (2006). Inflammation and insulin resistance. J Clin Invest 116, 1793-1801
21. Ryan AS, & Nicklas BJ. (2004). Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 27, 1699-1705
22. von Frankenberg AD, do Nascimento FV, Gatelli LE, et al. (2014). Major components of metabolic syndrome and adiponectin levels: a cross-sectional study. Diabetol Metab Syndr 6, 26
23. Arikoglu H, Ozdemir H, Kaya DE, et al. (2013). The adiponectin variants contribute to the genetic background of type 2 diabetes in Turkish population. Gene (epublication 26 October 2013
24. Hotta K, Funahashi T, Arita Y, et al. (2000). Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20, 1595-1599
25. Mather KJ, Funahashi T, Matsuzawa Y, et al. (2008). Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 57, 980-986
26. Gagnon C, Lu ZX, Magliano DJ, et al. (2011). Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 34, 1133-1138
27. Kayaniyil S, Retnakaran R, Harris SB, et al. (2011). Prospective associations of vitamin D with b-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes 60, 2947-2953
28. Forouhi NG, Luan J, Cooper A, et al. (2008). Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 57, 2619-2625
29. Zheng JS, Parnell LD, Smith CE, et al. (2014). Circulating 25-hydroxyvitamin D, IRS1 variant rs2943641, and insulin resistance: replication of a gene-nutrient interaction in 4 populations of different ancestries. Clin Chem 60, 186-196
30. Jain R, von Hurst PR, Stonehouse W, et al. (2012). Association of vitamin D receptor gene polymorphisms with insulin resistance and response to vitamin D. Metabolism 61, 293-301